LEO Pharma reports positive phase 2b results for temtokibart in atopic dermatitis

New England Biolabs achieves B Corporation recertification

TransCode Therapeutics completes initial patient dosing in TTX-MC138 Cohort 4 of Phase 1a clinical trial

Palatin presents symptom resolution data from Phase 3 dry eye disease trial

BioArctic expands exidavnemab trial to include Multiple System Atrophy patients

NeuroSense Therapeutics completes PrimeC commercial manufacturing scale-up

SCG releases SCG101 late-breaking clinical data in HBV-related hepatocellular carcinoma

Genprex signs new research agreement with University of Pittsburgh to advance diabetes gene therapy

AstraZeneca and Daiichi Sankyo's Enhertu shows strong results in early-stage breast cancer trial

Perfuse Therapeutics reports positive Phase 1/2a trial results for PER-001 intravitreal implant in glaucoma

Formosa Pharmaceuticals and Apotex sign Mexico licensing agreement for clobetasol propionate ophthalmic suspension

Adcentrx's ADRX-0706 granted US FDA Fast Track designation to treat advanced cervical cancer

Ajinomoto and RIBOMIC announce successful extension of nucleic acid aptamer pharmacokinetics

Innovent reports first patient dosed in efdamrofusp alfa (IBI302) Phase 2 study in diabetic macular edema

AstraZeneca secures EU approval for Calquence combo as first-line treatment in mantle cell lymphoma